Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 48
Filtrar
Más filtros

Tipo del documento
Intervalo de año de publicación
1.
Graefes Arch Clin Exp Ophthalmol ; 258(10): 2241-2249, 2020 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-32613575

RESUMEN

PURPOSE: To determine donor cornea contamination rate and to determine factors associated with cornea contamination. To assess the effect of hospitalization, intensive care unit (ICU) time, and antibiotic use on corneal contamination rate. To determine the spectrum of the contaminating microorganisms. METHODS: The contamination rate of 212 corneas, obtained by enucleation from April 2014 to January 2015 in a single eye bank, was assessed retrospectively according to age, sex, cause of death, systemic antibiotic use, hospitalization time, ICU time, mechanical ventilation (MV), death to enucleation interval (DEI), enucleation to processing interval (EPI), and corneal epithelial exposure grading. The relative risk (RR) and adjusted RR with a 95% confidence interval were calculated using IBM-SPSS 20.0. RESULTS: The contamination rate was 35.6% (n = 75). On multivariate analysis, ICU stay of 4 days or longer and enucleation to processing interval (EPI) greater than 7.4 h (RR 1.58, CI 0.96-2.60, P = 0.06) were associated with donor cornea contamination. Corneal contamination risk was highest from 4 to 6 days at the ICU (RR 3.40, CI 1.54-7.51, P < 0.01) and decreased after 7 days (RR 2.22, CI 1.00-4.93, P = 0.05). Coagulase-negative Staphylococcus was the most common isolated bacteria (69.6%). The frequency of gentamicin-resistant bacteria was higher among patients who stayed 4 days or longer at the ICU. CONCLUSION: Patients staying at the intensive care unit 4 days or longer showed increased risk of corneal contamination. This is an important result to consider further indication for cornea donation.


Asunto(s)
Trasplante de Córnea , Obtención de Tejidos y Órganos , Córnea , Bancos de Ojos , Humanos , Unidades de Cuidados Intensivos , Preservación de Órganos , Estudios Retrospectivos , Donantes de Tejidos
2.
Int J Retina Vitreous ; 10(1): 41, 2024 May 29.
Artículo en Inglés | MEDLINE | ID: mdl-38812063

RESUMEN

BACKGROUND: The use of povidone-iodine for ocular surface asepsis is widespread for intravitreal injections. They became frequent procedures, leading to serial exposure of patients' eyes to iodinated solutions. In this study, we investigate the changes in the ocular surface in patients submitted to repeated use of povidine for intravitreal injection of anti-VEGF asepsis, analyzing Ocular Surface Disease Index, non-invasive break up time, blinking quality, lipid layer, meniscus height and osmolarity. METHODS: This case-control study included 34 individuals (68 eyes), 14 males, 20 females aged 48 to 94. Inclusion criteria were individuals who received application of 2% povidone-iodine eyedrops for intravitreal injections treatment with the non-treated contralateral eye used as control. Ocular surface examinations were performed at a single occasion. A pre-intravitreal injection asepsis protocol with povidone-iodine was applied. All statistical analysis was performed using the STATA® 18.0 Software and a p-value = 0.05 was considered as the statistical significance value in all tests. RESULTS: The median number of IVIs in treated eyes was 12 (range 6-20). The results in treated eyes compared with untreated eyes were respectively : median OSDI 16 (IQR 6-39) and 12.5 (IQR 8-39) (p = 0.380); mean NIBUT 10.30 (SD ± 2.62) and 10.78 (SD ± 2.92) ( s, p = 0.476); median blinking quality 100 (IQR 100) and 100 (IQR 100 ) (%, p = 0.188); median lipid layer 87 (IQR 77-90) and 86 (IQR 74-100) (nm, p = 0.451); median meniscus height 0.22 (IQR 0.19-0,31) and 0.24 (IQR 0.20-0.27) (mm, p = 0.862), median Meibomian gland atrophy 33 (IQR 24-45) and 31.5 (IQR 25-39) (%, p = 0.524); and mean osmolarity 306.6 (SD ± 21.13) and 313.8 (SD ± 29) (mOsm, p = 0.297). There was no statistically significant relationship between the repetitive use of 2% iodinated solution and signs or symptoms compatible with dry eye syndrome in this group of patients. CONCLUSIONS: The findings suggest that 2% povidone iodine is a safe and efficacious agent for ocular surface antisepsis during intravitreal injections, not leading to substantial ocular surface modifications. This conclusion supports the continued use of povidone iodine in routine ophthalmic procedures without increased risk of inducing dry eye syndrome.

3.
J Clin Microbiol ; 49(9): 3346-7, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21775545

RESUMEN

Two devastating cases of multidrug-resistant Pseudomonas aeruginosa endophthalmitis after keratoplasty as the result of transmission from the same donor were confirmed by pulsed-field gel electrophoresis. Strategies for preventing donor-to-host transmission, such as the use of antimicrobial agents of greater efficacy and better methods for detecting microorganisms in preservation medium, could minimize this type of transmission.


Asunto(s)
Transmisión de Enfermedad Infecciosa , Endoftalmitis/microbiología , Queratoplastia Penetrante/efectos adversos , Tipificación Molecular , Infecciones por Pseudomonas/diagnóstico , Pseudomonas aeruginosa/aislamiento & purificación , Infección de la Herida Quirúrgica/microbiología , Adolescente , Adulto , Anciano , Antibacterianos/farmacología , Farmacorresistencia Bacteriana Múltiple , Electroforesis en Gel de Campo Pulsado , Endoftalmitis/diagnóstico , Humanos , Masculino , Infecciones por Pseudomonas/microbiología , Infecciones por Pseudomonas/transmisión , Pseudomonas aeruginosa/clasificación , Pseudomonas aeruginosa/efectos de los fármacos , Pseudomonas aeruginosa/genética , Infección de la Herida Quirúrgica/diagnóstico , Donantes de Tejidos
4.
PLoS Negl Trop Dis ; 14(9): e0008585, 2020 09.
Artículo en Inglés | MEDLINE | ID: mdl-32956360

RESUMEN

Hansen's disease (HD) belongs to the group of neglected diseases and can cause physical deformities and disabilities, in addition to leading to social discrimination. Ocular involvement in HD is estimated at 70-75% worldwide. About 10-50% suffer from severe ocular symptoms and loss of vision occurs in approximately 5% of cases. Ocular changes may persist or worsen even after patients are considered cured and it is necessary to better understand these conditions in order to determine the need for additional public policies. The objective of this study was to identify the prevalence of ocular involvement in patients with HD at two specialist referral centers for treatment of the disease. A cross-sectional study was conducted with ophthalmological evaluations of patients with HD from June 2017 to June 2018. Diagnostic ocular findings, corrected visual acuity, and refractive error were described. Findings were correlated with patients' clinical and epidemiological variables. A total of 86 patients were evaluated, with a mean age of 50.1 years, predominantly males (59.3%), and with multibacillary HD (92%). The prevalence of ophthalmologic changes was 100% and the most common were dysfunction of the Meibomian glands (89.5%) and dry eye syndrome (81.4%). Cataracts were observed in 22 patients (25.6%), but best corrected visual acuity was normal or near normal in 84 patients (97.7%) and there were no cases of bilateral blindness. Patients with some degree of physical disability had more ophthalmological alterations, involving both the ocular adnexa (p = 0.03) and the ocular globe (p = 0.04). Ocular involvement is common in patients with Hansen's disease, reinforcing the importance of ophthalmologic examination in the evaluation and follow-up of these patients.


Asunto(s)
Síndromes de Ojo Seco/patología , Infecciones Bacterianas del Ojo/patología , Lepra/patología , Glándulas Tarsales/patología , Agudeza Visual/fisiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Brasil , Catarata/patología , Estudios Transversales , Femenino , Humanos , Masculino , Glándulas Tarsales/microbiología , Persona de Mediana Edad , Enfermedades Desatendidas , Prevalencia , Adulto Joven
6.
Arq Bras Oftalmol ; 71(3): 375-80, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18641824

RESUMEN

PURPOSE: To determine the prevalence of early and late-stage age-related macular degeneration (ARMD) and its association with risk factors such as age, gender, smoking, body mass index, hypertension and diabetes history, cataracts and pseudophakia. DESIGN: Population-based cross-sectional study in an elderly Japanese-Brazilian population from Londrina (Paraná, Brazil). METHODS: The study included 483 (80.5%) of the 600 registered members of a local association for Japanese immigrants and their descendants, aged 60 years and up. The presence of early and late-stage age-related macular degeneration was determined using the standard protocol and the international classification system. RESULTS: The mean age of the study subjects was 71 years. The overall prevalence of age-related macular degeneration was 15.1% (CI 95%; 12-18.7). The prevalence of early-stage age-related macular degeneration was 13.8% (CI 95%; 10.9-17.3), geographic atrophy was present in 0.4% and neovascular age-related macular degeneration in 0.8%. Age-related macular degeneration was significantly (p=0.004) and linearly (p=0.001) associated with age. CONCLUSION: Our study population displays a prevalence of early and late-stage age-related macular degeneration and component lesions similar to those of other Western countries, and data suggest a higher prevalence than that reported for populations in Japan. Since the age-related macular degeneration prevalence tends to rise as the population ages, studies identifying risk factors and exploring prevention methods are becoming increasingly important.


Asunto(s)
Emigrantes e Inmigrantes/estadística & datos numéricos , Degeneración Macular/epidemiología , Distribución por Edad , Factores de Edad , Anciano , Anciano de 80 o más Años , Brasil/epidemiología , Distribución de Chi-Cuadrado , Estudios Transversales , Femenino , Humanos , Japón/etnología , Degeneración Macular/etiología , Masculino , Persona de Mediana Edad , Prevalencia , Factores de Riesgo , Distribución por Sexo
7.
Rev. bras. oftalmol ; 82: e0032, 2023. graf
Artículo en Inglés | LILACS | ID: biblio-1449770

RESUMEN

ABSTRACT This report describes a case of retinal racemose hemangioma that first presented as a vitreous hemorrhage. The authors present the case of a 47-year-old woman with a sudden 5-day painless visual loss in her left eye. At the first visit, the best-correct visual acuities were 20/20 in the right eye and hand motions in the left eyes. Ultrasonography showed an attached retina and a massive vitreous hemorrhage. Pars plana vitrectomy was performed and a dilatation of large vessels was detected bulging from the optic disc. The best-correct visual acuities on day 30 postoperatively was 20/25 in the left eye. Fundus angiography and spectral-domain optical coherence tomography angiography showed anomalous arteriovenous communications with no intervening capillaries. The diagnosis was racemose hemangioma, an arteriovenous malformation of group 2 retina based on the Archer classification.


RESUMO Este relato descreve um caso de hemangioma racemoso da retina que se apresentou inicialmente como hemorragia vítrea. Os autores apresentam o caso de uma mulher de 47 anos com perda visual súbita e indolor 5 dias antes no olho esquerdo. Na primeira visita, a melhor acuidade visual corrigida foi de 20/20 no olho direito e movimentos das mãos no olho esquerdo. A ultrassonografia mostrou uma retina aderida e uma hemorragia vítrea maciça. Foi realizada vitrectomia pars plana, sendo detectada proliferação de grandes vasos salientes do disco óptico. A acuidade visual no dia 30 de pós-operatório foi de 20/25 no olho esquerdo. A angiografia de retina e a angiotomografia de coerência óptica de domínio espectral mostraram comunicações arteriovenosas anômalas sem capilares intermediários. O diagnóstico foi hemangioma racemoso, uma malformação arteriovenosa da retina do grupo 2 com base na classificação de Archer.


Asunto(s)
Humanos , Femenino , Persona de Mediana Edad , Malformaciones Arteriovenosas/complicaciones , Vasos Retinianos/anomalías , Hemorragia Vítrea/etiología , Angiografía , Hemangioma/complicaciones , Malformaciones Arteriovenosas/cirugía , Malformaciones Arteriovenosas/diagnóstico , Enfermedades de la Retina , Vasos Retinianos/diagnóstico por imagen , Vitrectomía , Hemorragia Vítrea/cirugía , Hemorragia Vítrea/diagnóstico , Ultrasonografía , Tomografía de Coherencia Óptica , Hemangioma/cirugía , Hemangioma/diagnóstico
8.
Arq Bras Oftalmol ; 70(5): 814-22, 2007.
Artículo en Portugués | MEDLINE | ID: mdl-18157307

RESUMEN

PURPOSE: To describe the evolution of a series of cases of diffuse unilateral subacute neuroretinitis (DUSN) treated with albendazole. METHODS: Interventional case series. The authors developed a non-randomized clinical trial protocol to investigate the clinical evolution of diffuse unilateral subacute neuroretinitis cases treated with albendazole. According to protocol criteria up to now, six patients were selected that will be described separately. RESULTS: Of the six studied patients, four presented the worm. All six patients treated with the antiparasitic drug showed improvement of visual acuity and of chorioretinal scars. During the weeks of treatment, evidence of worm inactivation was documented for the four patients with visible worms. No adverse drug side effects were observed. CONCLUSIONS: The antiparasitic drug albendazole seems to be beneficial and safe in patients with diffuse unilateral subacute neuroretinitis. More studies are necessary to evaluate the effectiveness of albendazole in the treatment of diffuse unilateral subacute neuroretinitis.


Asunto(s)
Albendazol/uso terapéutico , Antiparasitarios/uso terapéutico , Infecciones Parasitarias del Ojo/tratamiento farmacológico , Retinitis/tratamiento farmacológico , Enfermedad Aguda , Adolescente , Adulto , Albendazol/administración & dosificación , Antiparasitarios/administración & dosificación , Niño , Coriorretinitis/tratamiento farmacológico , Coriorretinitis/parasitología , Coriorretinitis/patología , Infecciones Parasitarias del Ojo/patología , Femenino , Humanos , Masculino , Proyectos de Investigación , Retinitis/parasitología , Retinitis/patología , Índice de Severidad de la Enfermedad , Factores de Tiempo , Resultado del Tratamiento , Agudeza Visual/efectos de los fármacos , Pruebas del Campo Visual
9.
Arq Bras Oftalmol ; 80(4): 252-256, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28954027

RESUMEN

PURPOSE:: To evaluate and compare the effects of topical application and subconjunctival injection of bevacizumab on corneal neovascularization (CNV) in rabbits' eyes after chemical burning of the cornea. METHODS:: The animals were randomly distributed into four groups of five animals. In one group, the drug was instilled, while in another, it was administered by subconjunctival injection. The two procedures using bevacizumab were compared with instillation and subconjunctival injection of saline solution (S). Neovascularization was evaluated according to the size of the invasion area of new blood vessels and through computerized analysis of this area. The data were analyzed using the Kruskal-Wallis test followed by Dunn's test for two-by-two comparison of the groups, to assess the external examination of CNV. Analysis of variance was used to assess the area of CNV. P<0.05 was considered statistically significant. RESULTS:: Assessing both the external examination and the invasion area of neovessels on the 5th and 10th days, there was a clear difference between the groups. The group to which saline solution had been applied showed higher scores for CNV, as well as increases in the invasion area of neovessels. Two-by-two comparison of groups revealed no significant differences. However, an analysis of the factors involved (injection vs. instillation and bevacizumab vs. saline solution) showed that injection did not differ from instillation, but that bevacizumab differed from saline solution. CONCLUSION:: Bevacizumab showed an inhibitory effect on CNV in rabbits' eyes after chemical burning of the cornea. There was no difference between the topical or subconjunctival administration of bevacizumab in the inhibition of CNV.


Asunto(s)
Inhibidores de la Angiogénesis/administración & dosificación , Bevacizumab/administración & dosificación , Córnea/efectos de los fármacos , Neovascularización de la Córnea/tratamiento farmacológico , Administración Tópica , Animales , Quemaduras Químicas , Córnea/inervación , Lesiones de la Cornea/inducido químicamente , Neovascularización de la Córnea/patología , Modelos Animales de Enfermedad , Quemaduras Oculares , Inyecciones Intraoculares , Masculino , Soluciones Oftálmicas , Conejos , Distribución Aleatoria , Factores de Crecimiento Endotelial Vascular/antagonistas & inhibidores
10.
Rev. bras. oftalmol ; 81: e0016, 2022. graf
Artículo en Inglés | LILACS | ID: biblio-1365729

RESUMEN

ABSTRACT Reticular pigmentary retinal dystrophy, also known as Sjögren's reticular dystrophy, is a rare condition characterized by macular lesions with a reticular pattern, which are best seen on fluorescein angiogram. Choroidal neovascularization secondary to this type of dystrophy is even less common. This report describes a case of reticular pigmentary retinal dystrophy with vision loss due to neovascular membrane, which responded well to treatment with anti-vascular endothelial growth factor.


RESUMO A distrofia reticular pigmentar da retina, também conhecida como distrofia reticular de Sjögren, é uma doença rara, caracterizada por lesões maculares com um padrão reticular, que são mais bem visualizadas na angiografia com fluoresceína. A neovascularização de coroide secundária a este tipo de distrofia é ainda menos comum. Este relato descreve um caso de distrofia reticular pigmentar da retina, com perda de visão devido à membrana neovascular, que respondeu bem ao tratamento com fator de crescimento endotelial antivascular.


Asunto(s)
Humanos , Masculino , Anciano , Retinitis Pigmentosa/complicaciones , Neovascularización Coroidal/etiología , Neovascularización Coroidal/tratamiento farmacológico , Distrofias Retinianas/complicaciones , Ranibizumab/administración & dosificación , Síndrome de Sjögren/complicaciones , Estudios de Seguimiento , Neovascularización Coroidal/diagnóstico , Inhibidores de la Angiogénesis/administración & dosificación , Inhibidores de la Angiogénesis/uso terapéutico , Inyecciones Intravítreas , Ranibizumab/uso terapéutico
11.
Arq Bras Oftalmol ; 69(6): 837-43, 2006.
Artículo en Portugués | MEDLINE | ID: mdl-17273677

RESUMEN

PURPOSE: To evaluate the safety, effectiveness, and cost of angiofluoresceinographic examination by using both the least amount of dye as well as digital equipment along with a laser photocopier. METHODS: Prospective and comparative study carried out in a group of 70 patients, who underwent an angiographic evaluation with a conventional retinographer injecting 5 ml sodium fluorescein at 10% (control group) as well as a group of 70 patients who underwent an angiographic evaluation with a digital retinographer injecting 2 ml fluorescein at 10% (study group). Arterial pressure, heart rate and oximetry were assessed prior to and after the dye injection. Organic reactions related to the examination were reported. Photograph quality as well as cost between the two techniques were compared. RESULTS: Control group patients showed a greater increase in systolic and diastolic arterial pressure. Heart rate, oximetry measurement and adverse reactions did not show any significant statistical differences between both groups. As for the quality of photographs, a better performance was noticed in the control group. As for the cost, the examination carried out in the study group required lower cost and thus saved around 54.8% per examination in relation to the control group. CONCLUSION: The examination carried out with a lower dose of fluorescein using digital equipment along with a laser photocopier provided greater stability in the systolic and diastolic arterial pressure. However, it did not have any influence on heart rate, oximetry or adverse reactions such as nausea, vomiting, syncope and rashes. The quality of photographs was poor although they enabled diagnosis as well as therapy follow-up for those who carried out the examination. Moreover, economically the above procedure represented a gain of 66.26%, against 25.81% in relation to the conventional equipment.


Asunto(s)
Medios de Contraste/administración & dosificación , Angiografía con Fluoresceína , Fluoresceína/administración & dosificación , Enfermedades de la Retina/diagnóstico , Angiografía de Substracción Digital/economía , Angiografía de Substracción Digital/métodos , Angiografía de Substracción Digital/normas , Presión Sanguínea/efectos de los fármacos , Medios de Contraste/efectos adversos , Costos y Análisis de Costo , Fluoresceína/efectos adversos , Angiografía con Fluoresceína/efectos adversos , Angiografía con Fluoresceína/economía , Angiografía con Fluoresceína/métodos , Frecuencia Cardíaca/efectos de los fármacos , Humanos , Rayos Láser , Oximetría , Estudios Prospectivos , Factores de Tiempo , Vómitos/etiología
12.
Braz J Infect Dis ; 18(4): 364-71, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24662141

RESUMEN

This study describes the characteristics of 31 children with congenital toxoplasmosis children admitted to the University Hospital of Londrina, Southern Brazil, from 2000 to 2010. In total, 23 (85.2%) of the mothers received prenatal care but only four (13.0%) were treated for toxoplasmosis. Birth weight was <2500g in 37.9% of the infants. During the first month of life, physical examination was normal in 34.5%, and for those with clinical signs and symptoms, the main manifestations were hepatomegaly and/or splenomegaly (62.1%), jaundice (13.8%), and microcephaly (6.9%). During ophthalmic examination, 74.2% of the children exhibited injuries, 58.1% chorioretinitis, 32.3% strabismus, 19.4% microphthalmia, and 16.2% vitreitis. Anti-Toxoplasma gondii IgM antibodies were detected in 48.3% of the children. Imaging brain evaluation was normal in 44.8%; brain calcifications, hydrocephaly, or both conditions were observed in 27.6%, 10.3%, and 17.2%, respectively, of the patients. Patients with cerebrospinal fluid protein≥200mg/dL presented more brain calcifications (p=0.0325). Other sequelae were visual impairment (55.2% of the cases), developmental delay (31.0%), motor deficit (13.8%), convulsion (27.5%), and attention deficit (10.3%). All patients were treated with sulfadiazine, pyrimethamine, and folinic acid, and 55.2% of them exhibited adverse effects. The results demonstrate the significance of the early diagnosis and treatment of toxoplasmosis during pregnancy to reduce congenital toxoplasmosis and its consequences.


Asunto(s)
Anticuerpos Antiprotozoarios/sangre , Toxoplasma/inmunología , Toxoplasmosis Congénita/complicaciones , Toxoplasmosis Congénita/diagnóstico , Adolescente , Adulto , Brasil , Niño , Femenino , Humanos , Recién Nacido , Masculino , Tamizaje Neonatal , Embarazo , Complicaciones Infecciosas del Embarazo/terapia , Estudios Retrospectivos , Adulto Joven
13.
Arq Bras Oftalmol ; 77(3): 168-72, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25295904

RESUMEN

PURPOSE: This study aimed to evaluate the expression of the inflammatory cytokines TNF-α and IL-6 in the sclera and choroid of hypercholesterolemic rabbits. METHOD: Twenty-one New Zealand male albino rabbits were divided into two groups: NG and HG. The NG group was fed a standard rabbit diet and the HG group was fed a cholesterol-enriched diet (1%). The serum total cholesterol, triglyceride, HDL cholesterol, and fasting blood glucose levels were determined at the beginning of the experiment and on the day of euthanasia. Euthanasia of animals in the NG and HG groups was performed at the end of the 4th and 8th week, respectively. The eyes were analyzed immunohistochemically using TNF-α and IL-6 antibodies. RESULTS: At the time of euthanasia, the HG group showed a significant increase in total cholesterol and triglyceride when compared with the NG group (p<0.001). When compared with the NG group, there was a significant increase in the expression of TNF-α (p<0.001) and IL-6 (p=0.002) in the choroid and sclera of animals in the HG group. CONCLUSION: This study demonstrates that the hypercholesterolemic diet induces expression of TNF-α and IL-6 in the choroid and sclera of rabbits.


Asunto(s)
Coroides/metabolismo , Hipercolesterolemia/metabolismo , Interleucina-6/metabolismo , Esclerótica/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo , Animales , Colesterol en la Dieta , Coroides/patología , Modelos Animales de Enfermedad , Inmunohistoquímica , Interleucina-6/análisis , Degeneración Macular/metabolismo , Masculino , Conejos , Valores de Referencia , Esclerótica/patología , Factores de Tiempo , Factor de Necrosis Tumoral alfa/análisis , Factor A de Crecimiento Endotelial Vascular/análisis , Factor A de Crecimiento Endotelial Vascular/metabolismo
14.
Arq Bras Oftalmol ; 76(1): 1-5, 2013.
Artículo en Portugués | MEDLINE | ID: mdl-23812517

RESUMEN

PURPOSE: The aim of this study is to investigate the expression of vascular endothelial growth factor (VEGF) in the choroid and sclera using hypercholesterolemia experimental model. METHODS: New Zealand rabbits were divided into two groups: 8 rabbits (8 eyes), in the normal diet group (NG), were fed by a standard diet for 4 weeks; and 13 rabbits (13 eyes), in the hypercholesterolemic group (HG), were fed by a 1% cholesterol-enriched diet for 8 weeks. Total serum cholesterol, triglyceride, HDL cholesterol and fasting blood glucose exams were performed at the initiation of the experiment and at the euthanasia time. After hypercholesterolemic group 8th week and NG 4th week, animals were euthanized and their eyes underwent immunohistochemical analysis with the RAM-11 and VEGFR-1). RESULTS: The diet has induced a significant increase in total cholesterol and triglyceride levels in HG when compared with NG (p<0.001). There was a significant increase in the RAM-11 and VEGFR-1 expressions in hypercholesterolemic group choroid and sclera in relation to NG (p<0,001). CONCLUSION: This study has revealed that the hypercholesterolemic diet in rabbits induces an increase in the macrophage concentration and immunoreactivity to VEGFR-1 in the choroid and sclera, resembling human age-related macular degeneration (ARMD).


Asunto(s)
Colesterol en la Dieta/efectos adversos , Coroides/metabolismo , Hipercolesterolemia/metabolismo , Esclerótica/metabolismo , Receptor 1 de Factores de Crecimiento Endotelial Vascular/metabolismo , Animales , Coroides/patología , Modelos Animales de Enfermedad , Humanos , Hipercolesterolemia/etiología , Hipercolesterolemia/patología , Masculino , Conejos , Esclerótica/patología
15.
J Ocul Pharmacol Ther ; 29(8): 709-14, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23683100

RESUMEN

PURPOSE: Demonstrate that the blockade of angiotensin II AT-1 receptors, through the systemic administration of olmesartan, can reduce the MCP-1 expression and the resulting macrophage accumulation in the choroid and sclera of hypercholesterolemic rabbits. METHODS: Thirty-two New Zealand rabbits were divided into 3 groups: group I (GI) was fed a standard rabbit diet; group II (GII) was fed a hypercholesterolemic diet; and group III (GIII) was fed a hypercholesterolemic diet plus olmesartan. Serum levels of total cholesterol, triglyceride, HDL cholesterol, and blood glucose were determined in fasting rabbits at the beginning of the experiment and on the day of euthanasia. The choroid and sclera were submitted to morphometric analysis as well as immunohistochemical analysis with MCP-1 and RAM-11 (macrophage marker) antibodies. RESULTS: No abnormality was detected in GI. Group II and III had significant increases in choroid-sclera complex thicknesses when compared with group I (P<0.001). GII showed a significant increase in immunoreactivity for MCP-1 in relation to GI (P=0.001) and GIII (P=0.004). GII showed a significant increase in immunoreactivity for RAM-11 of the choroid-sclera complex in relation to GI (P<0.001) and GIII (P=0.034). A significant increase in immunoreactivity for RAM-11 was observed in GIII in relation to GI (P=0.008). CONCLUSION: Olmesartan reduced the MCP-1 expression and the resultant macrophage accumulation in the choroid-sclera complex of hypercholesterolemic rabbits.


Asunto(s)
Bloqueadores del Receptor Tipo 1 de Angiotensina II/uso terapéutico , Quimiotaxis de Leucocito/efectos de los fármacos , Coroides/efectos de los fármacos , Hipercolesterolemia/tratamiento farmacológico , Imidazoles/uso terapéutico , Esclerótica/efectos de los fármacos , Tetrazoles/uso terapéutico , Bloqueadores del Receptor Tipo 1 de Angiotensina II/administración & dosificación , Animales , Biomarcadores/sangre , Glucemia/análisis , Quimiocina CCL2/inmunología , Quimiotaxis de Leucocito/inmunología , Coroides/inmunología , Coroides/metabolismo , Coroides/patología , Modelos Animales de Enfermedad , Hipercolesterolemia/inmunología , Hipercolesterolemia/metabolismo , Hipercolesterolemia/patología , Imidazoles/administración & dosificación , Lípidos/sangre , Macrófagos/inmunología , Degeneración Macular/inmunología , Degeneración Macular/metabolismo , Degeneración Macular/patología , Degeneración Macular/prevención & control , Masculino , Conejos , Esclerótica/inmunología , Esclerótica/metabolismo , Esclerótica/patología , Tetrazoles/administración & dosificación
16.
Arq Bras Oftalmol ; 75(1): 59-60, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22552420

RESUMEN

To report a case of gyrate atrophy of the choroid and retina associated with retinal detachment. Hyperornithinemia confirmed the diagnosis of gyrate atrophy. Pars plana vitrectomy with silicone oil infusion was performed with good anatomical results, despite the persistence of low visual acuity. Retinal detachment is a rare complication of gyrate atrophy and can be managed with pars plana vitrectomy and silicone oil. We discuss the possible mechanisms that led to low visual acuity.


Asunto(s)
Coroides/patología , Atrofia Girata/complicaciones , Retina/patología , Desprendimiento de Retina/etiología , Adulto , Coroides/cirugía , Femenino , Humanos , Inyecciones Intravítreas , Retina/cirugía , Desprendimiento de Retina/terapia , Aceites de Silicona/administración & dosificación , Vitrectomía/métodos
17.
Arq. bras. oftalmol ; 80(4): 252-256, July-Aug. 2017. tab, graf
Artículo en Inglés | LILACS | ID: biblio-888121

RESUMEN

ABSTRACT Purpose: To evaluate and compare the effects of topical application and subconjunctival injection of bevacizumab on corneal neovascularization (CNV) in rabbits' eyes after chemical burning of the cornea. Methods: The animals were randomly distributed into four groups of five animals. In one group, the drug was instilled, while in another, it was administered by subconjunctival injection. The two procedures using bevacizumab were compared with instillation and subconjunctival injection of saline solution (S). Neovascularization was evaluated according to the size of the invasion area of new blood vessels and through computerized analysis of this area. The data were analyzed using the Kruskal-Wallis test followed by Dunn's test for two-by-two comparison of the groups, to assess the external examination of CNV. Analysis of variance was used to assess the area of CNV. P<0.05 was considered statistically significant. Results: Assessing both the external examination and the invasion area of neovessels on the 5th and 10th days, there was a clear difference between the groups. The group to which saline solution had been applied showed higher scores for CNV, as well as increases in the invasion area of neovessels. Two-by-two comparison of groups revealed no significant differences. However, an analysis of the factors involved (injection vs. instillation and bevacizumab vs. saline solution) showed that injection did not differ from instillation, but that bevacizumab differed from saline solution. Conclusion: Bevacizumab showed an inhibitory effect on CNV in rabbits' eyes after chemical burning of the cornea. There was no difference between the topical or subconjunctival administration of bevacizumab in the inhibition of CNV.


RESUMO Objetivos: Avaliar e comparar o efeito do uso tópico e da injeção subconjuntival do bevacizumabe na neovascularização corneana de olhos de coelhos após queimadura química. Métodos: Os animais foram distribuídos de forma aleatória em quatro grupos de cinco animais. Em um grupo de coelhos a droga foi instilada, enquanto em outro foi aplicada injeção subconjuntival, sendo os dois procedimentos comparados com a instilação e injeção subconjuntival de soro fisiológico 0,9% (SF) e entre si. A neovascularização foi avaliada conforme o tamanho da área de invasão dos neovasos e com análise computadorizada da mesma. Na análise de dados aplicou-se o teste de Kruskal-Wallis seguido do teste de Dunn com p<0,05 para comparação dos grupos dois a dois na análise do exame externo da neovascularização corneana. Na análise da área de neovascularização corneana, aplicou-se o teste F de análise de variância. A significância estatística foi definida como valor de p<0.05. Resultados: A avaliação do exame externo e da área de invasão de neovasos, no 5º e 10º dia, mostrou nítida diferença entre os grupos. Com o uso de soro fisiológico houve maior graduação na escala de neovascularização corneana e também na área de invasão dos nevasos, o que demonstrou o efeito inibitório do bevacizumabe. Nas comparações dos grupos dois a dois não foram detectadas diferenças significativas, porém, ao analisar os fatores envolvidos (procedimentos: injeção ou instilação, e as drogas: bevacizumabe ou soro fisiológico), verificou-se que a injeção não diferiu da instilação, mas o bevacizumabe diferiu do soro fisiológico. Conclusão: O bevacizumabe apresentou efeito inibitório na neovascularização corneana de olhos de coelhos após queimadura química, tanto por via tópica como por via subconjuntival e não houve diferença entre a via tópica e a via subconjuntival de administração do bevacizumabe na inibição da neovascularização corneana.


Asunto(s)
Animales , Masculino , Ratas , Neovascularización de la Córnea/tratamiento farmacológico , Córnea/efectos de los fármacos , Inhibidores de la Angiogénesis/administración & dosificación , Bevacizumab/administración & dosificación , Soluciones Oftálmicas , Quemaduras Químicas , Distribución Aleatoria , Quemaduras Oculares , Administración Tópica , Neovascularización de la Córnea/patología , Córnea/inervación , Factores de Crecimiento Endotelial Vascular/antagonistas & inhibidores , Modelos Animales de Enfermedad , Inyecciones Intraoculares , Lesiones de la Cornea/inducido químicamente
18.
Clinics (Sao Paulo) ; 67(9): 1047-52, 2012 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23018302

RESUMEN

OBJECTIVES: The objective of this study was to evaluate the relationship between the treatment of Helicobacter pylori gastric infection and changes in best-corrected visual acuity and macular detachment in patients with chronic central serous chorioretinopathy. METHODS: Seventeen patients diagnosed with central serous chorioretinopathy were examined for gastric infection with Helicobacter pylori using the urease test and gastric biopsy. Helicobacter pylory-positive patients were treated with the appropriate medication. The response to therapy was monitored by evaluating the best-corrected visual acuity and optical coherence tomography. The data were analyzed using Student's t-test before and after treatment. RESULTS: Fourteen patients (15 eyes) aged 30-56 years (mean 43.4 ± 8.3 years) were positive for Helicobacter pylori. Most of the positive patients had gastric symptoms (78.5%); one had bilateral central serous chorioretinopathy. The mean baseline best-corrected visual acuity was 20/98 (logMAR = 0.53 ± 0.28). Three months after starting treatment with antibiotics, the serous detachment had resolved in 14 of 15 eyes, but two cases required laser treatment. The follow-up period ranged from 6 to 27 months. The mean final best-corrected visual acuity differed significantly from baseline. CONCLUSION: Our findings suggest that Helicobacter pylori infection may be present in many chronic central serous chorioretinopathy patients and that treatment for the infection may have a favorable effect on the outcome of chronic central serous chorioretinopathy. Due to the possibility of the spontaneous regression of chronic central serous chorioretinopathy and the high prevalence of the infection in the general population, prospective and masked clinical trials are necessary to confirm that treatment for Helicobacter pylori infection may benefit patients with chronic central serous chorioretinopathy.


Asunto(s)
Coriorretinopatía Serosa Central/tratamiento farmacológico , Infecciones por Helicobacter/tratamiento farmacológico , Helicobacter pylori/efectos de los fármacos , Gastropatías/tratamiento farmacológico , Adulto , Enfermedad Crónica , Femenino , Angiografía con Fluoresceína , Estudios de Seguimiento , Infecciones por Helicobacter/diagnóstico , Humanos , Masculino , Persona de Mediana Edad , Desprendimiento de Retina/tratamiento farmacológico , Factores de Riesgo , Gastropatías/microbiología , Factores de Tiempo , Resultado del Tratamiento
19.
Arq Bras Oftalmol ; 75(1): 48-52, 2012.
Artículo en Portugués | MEDLINE | ID: mdl-22552418

RESUMEN

PURPOSE: The aim of this study is to experientially demonstrate that a cholesterol-enriched diet induces an increase in the MCP-1 expression in the choroid and sclera. METHOD: New Zealand rabbits were divided into two groups: GN (normal diet group) of 8 rabbits (8 eyes) was fed a standard rabbit diet for 4 weeks; GH (hypercholesterolemic group) of 13 rabbits (13 eyes) was fed a 1% cholesterol enriched diet for 8 weeks. Total serum cholesterol, triglyceride, HDL cholesterol and fasting blood glucose exams were performed at the start of the experiment and at the euthanasia time. After GH 8th week and GN 4th week animals were euthanized and their eyes underwent immunohistochemical analysis with the anti-MCP-1 antibody. RESULTS: The diet has induced a significant increase in GH total cholesterol and triglyceride levels when compared with NG (p<0.001). There was a significant increase in the MCP-1 expression in GH choroid and sclera in relation to GN (p<0.001). CONCLUSION: This study has revealed that the hypercholesterolemic diet in rabbits induces an increase in the MCP-1 expression in the choroid and sclera.


Asunto(s)
Quimiocina CCL2/metabolismo , Coroides/metabolismo , Hipercolesterolemia/metabolismo , Esclerótica/metabolismo , Animales , Colesterol en la Dieta/efectos adversos , Modelos Animales de Enfermedad , Hipercolesterolemia/etiología , Inmunohistoquímica , Masculino , Conejos
20.
J Ocul Pharmacol Ther ; 27(5): 535-7, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21830946

RESUMEN

PURPOSE: The aim of this study was to report a case of a 52-year-old man with a rare fungal endophthalmitis after penetrating ocular trauma with a fish hook. RESULTS: The patient was submitted to wound repair and hook extraction. Three weeks after the trauma, a cataract extraction with phacoemulsification and in-the-bag intraocular lens implantation was performed. After the development of endophthalmitis, vitrectomy and lens explantation with positive culture for Curvularia lunata were carried out. The infection was controlled with the administration of systemic itraconazole and intraocular voriconazole. CONCLUSIONS: The use of intravitreal voriconazole injection is a viable option in cases of Curvularia fungal endophthalmitis.


Asunto(s)
Antifúngicos/uso terapéutico , Endoftalmitis/microbiología , Infecciones Fúngicas del Ojo/microbiología , Antifúngicos/administración & dosificación , Ascomicetos/aislamiento & purificación , Extracción de Catarata/métodos , Endoftalmitis/tratamiento farmacológico , Infecciones Fúngicas del Ojo/tratamiento farmacológico , Humanos , Itraconazol/administración & dosificación , Itraconazol/uso terapéutico , Masculino , Persona de Mediana Edad , Facoemulsificación/métodos , Pirimidinas/administración & dosificación , Pirimidinas/uso terapéutico , Triazoles/administración & dosificación , Triazoles/uso terapéutico , Vitrectomía , Voriconazol
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA